0001179110-13-003998.txt : 20130304 0001179110-13-003998.hdr.sgml : 20130304 20130304163442 ACCESSION NUMBER: 0001179110-13-003998 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130228 FILED AS OF DATE: 20130304 DATE AS OF CHANGE: 20130304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Townsend Scott B CENTRAL INDEX KEY: 0001303192 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 13662069 MAIL ADDRESS: STREET 1: C/O CRITICAL THERAPEUTICS, INC. STREET 2: 60 WESTVIEW ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 edgar.xml FORM 4 - X0306 4 2013-02-28 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001303192 Townsend Scott B 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 SVP, General Counsel Common Stock 2013-02-28 4 A 0 4400 A 4400 D Common Stock 2013-02-28 4 A 0 7500 A 11900 D Stock Option (Right to Buy) 16.55 2013-02-28 4 A 0 26300 A 2023-02-28 Common Stock 26300 26300 D Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units (an "RSU Grant") pursuant to the Issuer's Second Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) in equal annual installments over the next three years thereafter. Not applicable. These shares of Common Stock are issuable pursuant to a market-based RSU Grant under the Plan and will vest, if at all, based on achievement of certain target performance of the Issuer's stock price at the end of the three-year period ending December 31, 2015. The number represents the maximum number of shares that may be delivered pursuant to the award. Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% vesting on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter. Nancy R. Smith, attorney-in-fact 2013-03-04